Artículos de revistas sobre el tema "A9 neurons"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "A9 neurons".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Haynes, John M., Shanti M. Sibuea, Alita A. Aguiar, Fangwei Li, Joan K. Ho y Colin W. Pouton. "Inhibition of β-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson’s disease". PLOS ONE 16, n.º 12 (23 de diciembre de 2021): e0261730. http://dx.doi.org/10.1371/journal.pone.0261730.
Texto completoFiorenzano, Alessandro, Edoardo Sozzi, Malin Parmar y Petter Storm. "Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing". Cells 10, n.º 6 (1 de junio de 2021): 1366. http://dx.doi.org/10.3390/cells10061366.
Texto completoGRENHOFF, J., L. UGEDO y T. H. SVENSSON. "Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells". Acta Physiologica Scandinavica 134, n.º 1 (septiembre de 1988): 127–32. http://dx.doi.org/10.1111/j.1748-1716.1988.tb08468.x.
Texto completoPujo, J., G. De Palma, J. Lu, S. M. Collins y P. Bercik. "A9 DORSAL ROOT GANGLIA NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE". Journal of the Canadian Association of Gastroenterology 4, Supplement_1 (1 de marzo de 2021): 10–11. http://dx.doi.org/10.1093/jcag/gwab002.008.
Texto completoYang, S., L. C. Edman, J. A. Sanchez-Alcaniz, N. Fritz, S. Bonilla, J. Hecht, P. Uhlen et al. "Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons". Journal of Cell Science 126, n.º 22 (15 de noviembre de 2013): e1-e1. http://dx.doi.org/10.1242/jcs.145136.
Texto completoStockton, Marsha E. y Kurt Rasmussen. "Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine Neurons". Neuropsychopharmacology 14, n.º 2 (febrero de 1996): 97–104. http://dx.doi.org/10.1016/0893-133x(94)00130-r.
Texto completoYang, S., L. C. Edman, J. A. Sanchez-Alcaniz, N. Fritz, S. Bonilla, J. Hecht, P. Uhlen et al. "Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons". Development 140, n.º 22 (23 de octubre de 2013): 4554–64. http://dx.doi.org/10.1242/dev.098145.
Texto completoGerman, Dwight C. y Kebreten F. Manaye. "Midbrain dopaminergic neurons (nuclei A8, A9, and A10): Three-dimensional reconstruction in the rat". Journal of Comparative Neurology 331, n.º 3 (15 de mayo de 1993): 297–309. http://dx.doi.org/10.1002/cne.903310302.
Texto completoBye, Christopher R., Lachlan H. Thompson y Clare L. Parish. "Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into Parkinsonian mice". Experimental Neurology 236, n.º 1 (julio de 2012): 58–68. http://dx.doi.org/10.1016/j.expneurol.2012.04.002.
Texto completoGoldstein, Jeffrey M., Linda C. Litwin, E. B. Sutton y Jeffrey B. Malick. "D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons". Life Sciences 40, n.º 11 (marzo de 1987): 1039–44. http://dx.doi.org/10.1016/0024-3205(87)90565-0.
Texto completoAldhshan, Muhammad S., Gursagar Jhanji, Nicole J. Poritsanos y Tooru M. Mizuno. "Glucose Stimulates Glial Cell Line-Derived Neurotrophic Factor Gene Expression in Microglia through a GLUT5-Independent Mechanism". International Journal of Molecular Sciences 23, n.º 13 (25 de junio de 2022): 7073. http://dx.doi.org/10.3390/ijms23137073.
Texto completoCourtois, Elise T., Claudia G. Castillo, Emma G. Seiz, Milagros Ramos, Carlos Bueno, Isabel Liste y Alberto Martínez-Serrano. "In Vitroandin VivoEnhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL". Journal of Biological Chemistry 285, n.º 13 (27 de enero de 2010): 9881–97. http://dx.doi.org/10.1074/jbc.m109.054312.
Texto completoLokwan, S. J. A., P. G. Overton, M. S. Berry y D. Clark. "Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons". Neuroscience 92, n.º 1 (agosto de 1999): 245–54. http://dx.doi.org/10.1016/s0306-4522(98)00748-9.
Texto completoKawashima, Naoya, Shigeru Okuyama, Tomohiro Omura, Shigeyuki Chaki y Kazuyuki Tomisawa. "Effect of NRA0160, a selective dopamine D4 receptor antagonist, on A9 and A10 dopmaine neurons in rats." Japanese Journal of Pharmacology 79 (1999): 231. http://dx.doi.org/10.1016/s0021-5198(19)34937-6.
Texto completoGerman, Dwight C., Eric L. Nelson, Chang-Lin Liang, Samuel G. Speciale, Christopher M. Sinton y Patricia K. Sonsalla. "The Neurotoxin MPTP Causes Degeneration of Specific Nucleus A8, A9 and A10 Dopaminergic Neurons in the Mouse". Neurodegeneration 5, n.º 4 (diciembre de 1996): 299–312. http://dx.doi.org/10.1006/neur.1996.0041.
Texto completoMorrow, Bret A., D. Eugene Redmond, Robert H. Roth y John D. Elsworth. "Development of A9/A10 dopamine neurons during the second and third trimesters in the African green monkey". Journal of Comparative Neurology 488, n.º 2 (2005): 215–23. http://dx.doi.org/10.1002/cne.20599.
Texto completoIyengar, Smriti, Vicki M. Dilworth, Steven J. Mick, Patricia C. Contreras, Joseph B. Monahan, Tadimeti S. Rao y Paul L. Wood. "Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors". Brain Research 524, n.º 2 (agosto de 1990): 322–26. http://dx.doi.org/10.1016/0006-8993(90)90709-k.
Texto completoSorensen, Stephen M., Teresa M. Humphreys y Michael G. Palfreyman. "Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons". European Journal of Pharmacology 163, n.º 1 (abril de 1989): 115–18. http://dx.doi.org/10.1016/0014-2999(89)90402-0.
Texto completoFreeman, Arthur S. y Benjamin S. Bunney. "Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin". Brain Research 405, n.º 1 (marzo de 1987): 46–55. http://dx.doi.org/10.1016/0006-8993(87)90988-7.
Texto completoLjungberg, T., P. Apicella y W. Schultz. "Responses of monkey dopamine neurons during learning of behavioral reactions". Journal of Neurophysiology 67, n.º 1 (1 de enero de 1992): 145–63. http://dx.doi.org/10.1152/jn.1992.67.1.145.
Texto completoYeap, Yee Jie, Tng J. W. Teddy, Mok Jung Lee, Micaela Goh y Kah Leong Lim. "From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy". International Journal of Molecular Sciences 24, n.º 3 (28 de enero de 2023): 2523. http://dx.doi.org/10.3390/ijms24032523.
Texto completoTrudler, Dorit, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan et al. "Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia". Proceedings of the National Academy of Sciences 118, n.º 15 (8 de abril de 2021): e2025847118. http://dx.doi.org/10.1073/pnas.2025847118.
Texto completoO’Keeffe, Fiona E., Sarah A. Scott, Pam Tyers, Gerard W. O’Keeffe, Jeffrey W. Dalley, Romain Zufferey y Maeve A. Caldwell. "Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease". Brain 131, n.º 3 (17 de enero de 2008): 630–41. http://dx.doi.org/10.1093/brain/awm340.
Texto completoKawashima, Naoya, Shigeru Okuyama, Tomohiro Omura, Shigeyuki Chaki y Kazuyuki Tomisawa. "Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats". Life Sciences 65, n.º 24 (noviembre de 1999): 2561–71. http://dx.doi.org/10.1016/s0024-3205(99)00525-1.
Texto completoSánchez-Arroyos, Ricardo y Xavier Guitart. "Electrophysiological effects of E-5842, a σ1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons". European Journal of Pharmacology 378, n.º 1 (julio de 1999): 31–37. http://dx.doi.org/10.1016/s0014-2999(99)00440-9.
Texto completoHand, Timothy H., Xiu-Ti Hu y Rex Y. Wang. "Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons". Brain Research 415, n.º 2 (julio de 1987): 257–69. http://dx.doi.org/10.1016/0006-8993(87)90207-1.
Texto completoBusti, Daniela, Thomas Bienvenu, Ben Micklem, Peter J. Magill, Ryuichi Shigemoto, Marco Capogna y Francesco Ferraguti. "Morphological characterization of large intercalated neurons provides novel insight on intrinsic networks of the amygdala". BMC Pharmacology 11, Suppl 2 (2011): A9. http://dx.doi.org/10.1186/1471-2210-11-s2-a9.
Texto completoKuan, Wei-Li, Rachel Lin, Pam Tyers y Roger A. Barker. "The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias". Neurobiology of Disease 25, n.º 3 (marzo de 2007): 594–608. http://dx.doi.org/10.1016/j.nbd.2006.11.001.
Texto completoMereu, Giampaolo, Francesco Muntoni, Paolo Calabresi, Franco Romani, Virgilio Boi y Gian Luigi Gessa. "Responsiveness to ‘autoreceptor’ doses of apomorphine is inversely correlated with the firing rate of dopaminergic A9 neurons: Action of baclofen". Neuroscience Letters 65, n.º 2 (abril de 1986): 161–66. http://dx.doi.org/10.1016/0304-3940(86)90297-1.
Texto completoWhite, F. J. y R. Y. Wang. "Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat". Neuropharmacology 25, n.º 9 (septiembre de 1986): 995–1001. http://dx.doi.org/10.1016/0028-3908(86)90193-0.
Texto completoRomo, R. y W. Schultz. "Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements". Journal of Neurophysiology 63, n.º 3 (1 de marzo de 1990): 592–606. http://dx.doi.org/10.1152/jn.1990.63.3.592.
Texto completoPenna, Vanessa, Niamh Moriarty, Yi Wang, Kevin C. L. Law, Carlos W. Gantner, Richard J. Williams, David R. Nisbet y Clare L. Parish. "Extracellular Matrix Biomimetic Hydrogels, Encapsulated with Stromal Cell-Derived Factor 1, Improve the Composition of Foetal Tissue Grafts in a Rodent Model of Parkinson’s Disease". International Journal of Molecular Sciences 23, n.º 9 (22 de abril de 2022): 4646. http://dx.doi.org/10.3390/ijms23094646.
Texto completoRedmond, Andy J., Bret A. Morrow, John D. Elsworth y Robert H. Roth. "Selective activation of the A10, but not A9, dopamine neurons in the rat by the predator odor, 2,5-dihydro-2,4,5-trimethylthiazoline". Neuroscience Letters 328, n.º 3 (agosto de 2002): 209–12. http://dx.doi.org/10.1016/s0304-3940(02)00566-9.
Texto completoSeiz, E. G., M. Ramos-Gómez, E. T. Courtois, I. Liste y A. Martínez-Serrano. "3.340 HUMAN MIDBRAIN PRECURSORS DIFFERENTIATE TO MATURE FUNCTIONAL A9 DOPAMINE NEURONS IN VITRO. SHORT AND LONG-TERM ENHANCEMENT BY BCL-XL". Parkinsonism & Related Disorders 18 (enero de 2012): S229. http://dx.doi.org/10.1016/s1353-8020(11)70973-7.
Texto completoKuter, Katarzyna, Klemencja Berghauzen-Maciejewska, Anna Górska, Katarzyna Kamińska, Jadwiga Wardas, Krystyna Gołembiowska y Krystyna Ossowska. "The 6-hydroxydopamine-induced lesion of A8 and A9 mesencephalic dopaminergic neurons decreases the harmaline-induced glutamate release in the cerebellum". Pharmacological Reports 65 (mayo de 2013): 61–62. http://dx.doi.org/10.1016/s1734-1140(13)71349-5.
Texto completoPiontek, Julie A. y Rex Y. Wang. "Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat". Life Sciences 39, n.º 7 (agosto de 1986): 651–58. http://dx.doi.org/10.1016/0024-3205(86)90047-0.
Texto completoOverton, Paul y David Clark. "Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat". Synapse 10, n.º 2 (febrero de 1992): 131–40. http://dx.doi.org/10.1002/syn.890100208.
Texto completoKolasiewicz, Wacław, Katarzyna Kuter, Klemencja Berghauzen, Przemysław Nowak, Gert Schulze y Krystyna Ossowska. "6-OHDA injections into A8–A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats". Brain Research 1477 (octubre de 2012): 59–73. http://dx.doi.org/10.1016/j.brainres.2012.08.015.
Texto completoSánchez-Danés, A., A. Consiglio, Y. Richaud, I. Rodríguez-Pizà, B. Dehay, M. Edel, J. Bové et al. "Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells". Human Gene Therapy 23, n.º 1 (enero de 2012): 56–69. http://dx.doi.org/10.1089/hum.2011.054.
Texto completoBymaster, Franklin, Kenneth W. Perry, David L. Nelson, David T. Wong, Kurt Rasmussen, Nick A. Moore y David O. Calligaro. "Olanzapine: a basic science update". British Journal of Psychiatry 174, S37 (febrero de 1999): 36–40. http://dx.doi.org/10.1192/s0007125000293653.
Texto completoGoldstein, Jeffrey M. y Linda C. Litwin. "Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390". European Journal of Pharmacology 155, n.º 1-2 (octubre de 1988): 175–80. http://dx.doi.org/10.1016/0014-2999(88)90419-0.
Texto completoCzaniecki, Christopher, Tammy Ryan, Morgan G. Stykel, Jennifer Drolet, Juliane Heide, Ryan Hallam, Shalandra Wood et al. "Axonal pathology in hPSC-based models of Parkinson’s disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus". Proceedings of the National Academy of Sciences 116, n.º 28 (24 de junio de 2019): 14280–89. http://dx.doi.org/10.1073/pnas.1900576116.
Texto completoNgwa, Conelius, Abdullah Al Mamun, Yan Xu, Romana Sharmeen y Fudong Liu. "Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia". Cells 10, n.º 2 (30 de enero de 2021): 276. http://dx.doi.org/10.3390/cells10020276.
Texto completoSeiz, Emma G., Milagros Ramos-Gómez, Elise T. Courtois, Jan Tønnesen, Merab Kokaia, Isabel Liste Noya y Alberto Martínez-Serrano. "Human midbrain precursors activate the expected developmental genetic program and differentiate long-term to functional A9 dopamine neurons in vitro. Enhancement by Bcl-XL". Experimental Cell Research 318, n.º 19 (noviembre de 2012): 2446–59. http://dx.doi.org/10.1016/j.yexcr.2012.07.018.
Texto completoRasmussen, Kurt, Mei-Ann Hsu y Yili Yang. "The Orexin-1 Receptor Antagonist SB-334867 Blocks the Effects of Antipsychotics on the Activity of A9 and A10 Dopamine Neurons: Implications for Antipsychotic Therapy". Neuropsychopharmacology 32, n.º 4 (25 de octubre de 2006): 786–92. http://dx.doi.org/10.1038/sj.npp.1301239.
Texto completoTaleb, Omar, Mohammed Maammar, Christian Klein, Michel Maitre y Ayikoe Guy Mensah-Nyagan. "A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity". International Journal of Molecular Sciences 22, n.º 13 (28 de junio de 2021): 6974. http://dx.doi.org/10.3390/ijms22136974.
Texto completoBanrezes, Bernadette, Yves Maurin y Catherine Verney. "Intrauterine growth retardation does not alter the distribution of tyrosine hydroxylase-immunoreactive neurons of A8, A9 and A10 groups in the rat: a three-dimensional reconstruction study". Developmental Brain Research 126, n.º 1 (enero de 2001): 13–20. http://dx.doi.org/10.1016/s0165-3806(00)00121-8.
Texto completoKulas, Joshua A., Whitney F. Franklin, Nicholas A. Smith, Gunjan D. Manocha, Kendra L. Puig, Kumi Nagamoto-Combs, Rachel D. Hendrix, Giulio Taglialatela, Steven W. Barger y Colin K. Combs. "Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues". American Journal of Physiology-Endocrinology and Metabolism 316, n.º 1 (1 de enero de 2019): E106—E120. http://dx.doi.org/10.1152/ajpendo.00279.2018.
Texto completoOsacka, J., L. Horvathova, Z. Majercikova y Alexander Kiss. "Eff ect of a single asenapine treatment on Fos expression in the brain catecholamine-synthesizing neurons: impact of a chronic mild stress preconditioning". Endocrine Regulations 51, n.º 2 (25 de abril de 2017): 73–83. http://dx.doi.org/10.1515/enr-2017-0007.
Texto completoMoore, A. E., F. Cicchetti, J. Hennen y O. Isacson. "Parkinsonian Motor Deficits Are Reflected by Proportional A9/A10 Dopamine Neuron Degeneration in the Rat". Experimental Neurology 172, n.º 2 (diciembre de 2001): 363–76. http://dx.doi.org/10.1006/exnr.2001.7823.
Texto completo